AYURVEDIC CDC MULTIMODAL PROTOCOL FOR TYPE 2 DIABETES MELLITUS AT MADHAVBAUG CLINIC: GLYCAEMIC AND CARDIOMETABOLIC OUTCOMES IN 97 DM PACKAGE PATIENTS - A RETROSPECTIVE OBSERVATIONAL STUDY
- MD and CEO, Vaidya Sane Ayurved Laboratories Limited.
- Chief Medical Officer, Vaidya Sane Ayurved Laboratories Limited.
- Head Medical Operations, Vaidya Sane Ayurved Laboratories Limited.
- Zonal Medical Head, Madhavbaug Clinics, Maharashtra, India.
- Clinic Head, Madhavbaug Gandhinagar Pramukh Clinic, Gujarat, India.
0 Downloads
45 Views
Abstract
Background: Gandhinagar, Gujarat's capital city, serves a large population of government employees, administrative professionals, and their families, characterized by predominantly sedentary desk -based occupat Ions and stable incomes a demographic with high T2DM risk despite relatively controlled environmental exposures. The Gandhinagar cohort is the largest by patient number (n=97) in the Gujarat RIC DM network and the youngest (mean age 42.8 years), making it the most critical site for evaluating early intervention outcomes.
Objective: To evaluate the effect of the Madhavbaug CDC Panchakarma based multimodal protocol on glycaemic, anthropometric, haemodynamic, and cardiometabolic parameters, and antidiabetic medication reduction, in 97 DM Package patients at Gandhinagar Pramukh Clinic.
Keywords
How to Cite This Article
Dr. Rohit Sane et, al (2026); AYURVEDIC CDC MULTIMODAL PROTOCOL FOR TYPE 2 DIABETES MELLITUS AT MADHAVBAUG CLINIC: GLYCAEMIC AND CARDIOMETABOLIC OUTCOMES IN 97 DM PACKAGE PATIENTS - A RETROSPECTIVE OBSERVATIONAL STUDY, International Journal of Advanced Research (IJAR), 14 (06), 58-63, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/23588
Corresponding Author
Article Analytics
Similar Articles
0
52
1
82
29
165
12
138
41
185
This work is licensed under a Creative Commons Attribution 4.0 International License.





